Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease barrett esophagus
Comorbidity C0017168|esophageal reflux disease
Sentences 6
PubMedID- 25632808 Adiponectin may modify the risk of barrett's esophagus in patients with gastroesophageal reflux disease.
PubMedID- 20931428 Conclusions: patients with progressive systemic sclerosis have a higher tendency to the more severe forms and complications of gastroesophageal reflux disease including barrett's esophagus than in those without progressive systemic sclerosis.
PubMedID- 20086178 Gastroesophageal reflux disease complicated by barrett's esophagus (be) is a major risk factor for esophageal adenocarcinoma (ea).
PubMedID- 23504527 barrett's esophagus, with gastroesophageal reflux disease and obesity as risk factors, predisposes to esophageal adenocarcinoma (eac).
PubMedID- 23679035 In young adults gastroesophageal reflux disease occurs frequently with development of barrett esophagus in 6% reported in different series.
PubMedID- 25804032 [prospects for improving the management tactics for patients with gastroesophageal reflux disease complicated by barrett's esophagus].

Page: 1